# SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation

> **NCT07445789** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Martini Hospital Groningen** · enrollment: 436 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)

## Interventions

- **DRUG:** Verapamil 240 mg slow-release tablet
- **DRUG:** metoprolol 100 mg slow-release tablet

## Key facts

- **NCT ID:** NCT07445789
- **Lead sponsor:** Martini Hospital Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2029-06
- **Final completion:** 2029-06
- **Target enrollment:** 436 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07445789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07445789, "SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07445789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*